Data from the UK’s National Health Service EndoBarrier Service show a significant reduction in HbA1c, weight, liver fat, and cardiovascular disease risks as well as a reduction in the need for insulin in some patients.
News & Features
Alcon paid $285 million to acquire PowerVision, a company developing fluid-based intraocular lens implants.
The Cupertino, CA-based company released preliminary data from the Apple Heart Study, which demonstrates the effectiveness of wearables to detect atrial fibrillation.
R-One is the first European robotic solution to obtain the CE mark in the field of interventional cardiology.
Harvard Researchers have shed light on the liver and kidneys after toxin exposure, using machine learning.
With the EU Medical Device Regulations just over one year away, this latest revision aims to help medical device manufacturers meet the regulation’s General Safety and Performance Requirements.
FDA is calling on the public, scientists, and industry to help enhance the agency's understanding of materials science and to advance the development of safer medical device materials.
FDA urges collaboration, but healthcare system limitations and FDA guidance prompt medical devices to be secure by design to ensure patient safety.
The Abbott Park, IL-based company’s expanded indication would allow the MitraClip to address the secondary form of mitral regurgitation and would significantly increase the amount of people with MR able to be treated by the device.
The Kalamazoo, MI-based company is expected to pay $110 million up front, plus an additional $110 million in milestones to pick up OrthoSpace.
Watchman has been a significant driver for Boston Scientific and is expected to have strong growth this year as well.
A medtech analyst says recent developments have created more uncertainty about paclitaxel-coated balloons and stents.